Back to UBS Group AG UBS Group AG

SABSSABS
16 quarters

Position history for UBS Group AGUBS Group AG's holdings in SAB BIOTHERAPEUTICS INC

UBS Group AG holds 365,878 shares of SABS (SAB BIOTHERAPEUTICS INC), worth $1.4M as of 2026-Q2. The position was increased (+684.8% shares). SABS represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.4M

Current Shares

365,878

Total Value Change

+$1.4M

Total Shares Change

+359,925

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
365,878
+684.8%
$1.4M0.0%$3.90
41
2026-Q1
Increased
46,623
+530.2%
$178,5670.0%$3.89
25
2025-Q4
Decreased
7,398
-44.0%
$27,6680.0%$3.77
0
2025-Q3
Increased
13,221
+24.1%
$26,5740.0%$1.95
16
2025-Q2
Increased
10,658
+136x
$18,7050.0%$1.69
20
2025-Q1
Decreased
78
-92.8%
$1060.0%$1.48
0
2024-Q4
New
1,083
-
$4,1090.0%$4.15
22
2024-Q1
Exited
0
-100.0%
$00.0%$4.54
0
2023-Q4
New
500
-
$3440.0%$6.88
17
2023-Q2
Exited
0
-100.0%
$00.0%$7.73
0
2023-Q1
Decreased
6,679
-3.6%
$2,9390.0%$4.19
0
2022-Q4
Increased
6,927
+360.6%
$4,0870.0%$5.90
16
2022-Q3
Increased
1,504
+50.4%
$1,0000.0%$6.72
11
2022-Q2
Decreased
1,000
-28.9%
$1,0000.0%$13.90
0
2022-Q1
Decreased
1,407
-76.4%
$6,0000.0%$26.00
0
2021-Q4
New
5,953
-
$47,0000.0%$79.60
31

Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used